Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19.
Saved in:
| Title: | Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19. |
|---|---|
| Authors: | Bline K; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, United States., Andrews A; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States., Moore-Clingenpeel M; Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, United States., Mertz S; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States., Ye F; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States., Best V; Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States., Sayegh R; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States., Tomatis-Souverbielle C; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States., Quintero AM; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States., Maynard Z; Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States., Glowinski R; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States., Mejias A; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States., Ramilo O; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States. |
| Source: | Frontiers in pediatrics [Front Pediatr] 2022 Jun 06; Vol. 10, pp. 893045. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101615492 Publication Model: eCollection Cited Medium: Print ISSN: 2296-2360 (Print) Linking ISSN: 22962360 NLM ISO Abbreviation: Front Pediatr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35733812 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bline+K%22">Bline K</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Andrews+A%22">Andrews A</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Moore-Clingenpeel+M%22">Moore-Clingenpeel M</searchLink>; Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Mertz+S%22">Mertz S</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Ye+F%22">Ye F</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Best+V%22">Best V</searchLink>; Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Sayegh+R%22">Sayegh R</searchLink>; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Tomatis-Souverbielle+C%22">Tomatis-Souverbielle C</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Quintero+AM%22">Quintero AM</searchLink>; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Maynard+Z%22">Maynard Z</searchLink>; Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Glowinski+R%22">Glowinski R</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Mejias+A%22">Mejias A</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States.<br /><searchLink fieldCode="AU" term="%22Ramilo+O%22">Ramilo O</searchLink>; Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Infectious Disease, Nationwide Children's Hospital, Columbus, OH, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101615492%22">Frontiers in pediatrics</searchLink> [Front Pediatr] 2022 Jun 06; Vol. 10, pp. 893045. <i>Date of Electronic Publication: </i>2022 Jun 06 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+SA%22">Frontiers Media SA </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101615492 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-2360 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222962360%22">22962360 </searchLink><i>NLM ISO Abbreviation: </i>Front Pediatr <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35733812 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fped.2022.893045 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 893045 Titles: – TitleFull: Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bline K – PersonEntity: Name: NameFull: Andrews A – PersonEntity: Name: NameFull: Moore-Clingenpeel M – PersonEntity: Name: NameFull: Mertz S – PersonEntity: Name: NameFull: Ye F – PersonEntity: Name: NameFull: Best V – PersonEntity: Name: NameFull: Sayegh R – PersonEntity: Name: NameFull: Tomatis-Souverbielle C – PersonEntity: Name: NameFull: Quintero AM – PersonEntity: Name: NameFull: Maynard Z – PersonEntity: Name: NameFull: Glowinski R – PersonEntity: Name: NameFull: Mejias A – PersonEntity: Name: NameFull: Ramilo O IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 06 Text: 2022 Jun 06 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2296-2360 Numbering: – Type: volume Value: 10 Titles: – TitleFull: Frontiers in pediatrics Type: main |
| ResultId | 1 |